A completely absorbed oral preparation of digoxin.
Digoxin absorption was studied in healthy volunteers by determination of peak plasma concentrations, areas under plasma concentration curves, and urinary excretion after single-dose administration. By comparison with an aqueous solution, increased rate and extent of absorption occurred from experimental soft gelatin formulations of digoxin in solution. Enhanced bioavailability of the capsules was not affected by altered volume of contained solvent. Digoxin was considerably better absorbed from capsules than from tablets of moderately high dissolution rate. Mean percentage intestinal absorption was 75% from tablet and 97% from capsules. Reduced between-subject variability accompanied the enhanced absorption from capsules.
D000284:Administration, Oral; D000328:Adult; D001682:Biological Availability; D002214:Capsules; D004077:Digoxin / Q000008:administration & dosage* / Q000097:blood / Q000652:urine; D005260:Female; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D013607:Tablets; D013997:Time Factors
D002214:Capsules; D013607:Tablets; D004077:Digoxin